Therapeutic Effects of BT2 in the Hippocampus of Alzheimer's Disease Mouse Model

OBJECTIVES: Alzheimer's disease (AD) is the most common type of dementia affecting more than 6 million Americans today. Despite the increasing rates of AD there is still no effective cure for this devastating disease. Our lab has shown that elevated plasma branched-chain amino acids (BCAAs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullins, Caitlyn, Mohankumar, Puliyur Seshadri, Reddy, Hemachandra, Shah, Harsh, Shin, Andrew, Siddik, Bakkar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Aging and Chronic Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193317/
http://dx.doi.org/10.1093/cdn/nzac047.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193317/
http://dx.doi.org/10.1093/cdn/nzac047.041

Ejemplares similares